Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-09-079129
Filing Date
2009-04-15
Accepted
2009-04-15 06:08:46
Documents
7
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 CORTEX PHARMACEUTICALS FORM 10-K d10k.htm 10-K 1109769
2 SUBSIDIARIES OF THE REGISTRANT dex21.htm EX-21 1033
3 CONSENT OF HASKELL & WHITE LLP dex231.htm EX-23.1 2340
4 CERTIFICATION BY CEO - SECTION 302 dex311.htm EX-31.1 8895
5 CERTIFICATION BY CFO - SECTION 302 dex312.htm EX-31.2 9246
6 CERTIFICATION BY CEO AND CFO - SECTION 906 dex32.htm EX-32 4641
7 GRAPHIC g62744g87k10.jpg GRAPHIC 47957
  Complete submission text file 0001193125-09-079129.txt   1203533
Mailing Address 15241 BARRANCA PARKWAY IRVINE CA 92718
Business Address 15241 BARRANCA PKWY IRVINE CA 92718 7147273157
CORTEX PHARMACEUTICALS INC/DE/ (Filer) CIK: 0000849636 (see all company filings)

EIN.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-16467 | Film No.: 09749762
SIC: 2834 Pharmaceutical Preparations